NEU 6.41% $15.27 neuren pharmaceuticals limited

Share Price, page-4707

  1. 1,139 Posts.
    lightbulb Created with Sketch. 537
    Regarding the NNZ-2591 trials, looking at the Clinical Trials website I don’t see any changes to the estimated completion date for the Phelan-McDiarmid trial yet. I believe changes can still occur even at the last minute so to speak, so I’m expecting a slight delay (I certainly hope it finishes on time). Only question is how quickly could we see preliminary results?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.